Form 4: Martha Shadan Reports Acquisition of Dividend Equivalent Rights in LeMaitre Vascular Inc.

Director Martha Shadan reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards in LeMaitre Vascular Inc.

Summary

• On August 29, 2024, Martha Shadan, a director of LeMaitre Vascular Inc. (LMAT), reported the acquisition of dividend equivalent rights.
• These rights are associated with restricted stock unit (RSU) and performance share unit (PSU) awards previously granted on December 12, 2022, and December 8, 2023.
• Specifically, 0.7254 dividend equivalent rights were acquired related to the RSU award from December 12, 2022, 0.7254 related to the PSU award from December 12, 2022, and 0.9285 related to the RSU award from December 8, 2023.
• Each dividend equivalent right is economically equivalent to one share of LeMaitre Vascular's common stock.
• The reported transaction did not involve a direct purchase of common stock but rather the accrual of rights linked to existing equity awards.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The filing reflects standard compensation practices and insider alignment with shareholder interests. There are no indications of negative events or concerns.

Positives

• The acquisition of dividend equivalent rights indicates continued alignment of the director's interests with those of the shareholders.
• The vesting of these rights is tied to the vesting of underlying equity awards, incentivizing long-term performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider transactions, allowing investors to monitor the actions of company directors and officers.

Stakeholder Impact

• The disclosure provides transparency to shareholders regarding director compensation and alignment of interests.

Key Dates